ACTR-28. FINAL RESULTS FROM THE DOSE-ESCALATION STAGE OF A PHASE 1/2 TRIAL OF TPI 287, A BRAIN PENETRABLE MICROTUBULE INHIBITOR, PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

The file will be sent to you via the Telegram messenger. It may take up to 1-5 minutes before you receive it.

Note: Make sure you have linked your account to Z-Library Telegram bot.

The file will be sent to your Kindle account. It may take up to 1–5 minutes before you receive it.

Please note: you need to verify every book you want to send to your Kindle. Check your mailbox for the verification email from Amazon Kindle.